Cellectis S.A.
CLLS
$2.85
-$0.01-0.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.00M | -60.53M | -36.76M | -84.48M | -78.91M |
| Total Depreciation and Amortization | 19.74M | 19.45M | 19.09M | 19.13M | 18.88M |
| Total Amortization of Deferred Charges | 758.00K | 758.00K | 758.00K | 69.00K | 69.00K |
| Total Other Non-Cash Items | 27.09M | 18.13M | -13.76M | 20.59M | -440.00K |
| Change in Net Operating Assets | -21.94M | 51.34M | 53.67M | 107.44M | 111.89M |
| Cash from Operations | -33.35M | 29.14M | 22.99M | 62.75M | 51.49M |
| Capital Expenditure | -2.03M | -2.76M | -2.58M | -2.31M | -1.85M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.80M | -93.77M | -100.23M | -97.49M | -120.59M |
| Cash from Investing | -42.82M | -96.53M | -102.81M | -99.80M | -122.43M |
| Total Debt Issued | 6.99M | 6.95M | 23.20M | 17.71M | 23.37M |
| Total Debt Repaid | -15.84M | -15.87M | -16.06M | -16.35M | -16.33M |
| Issuance of Common Stock | 206.00K | 83.03M | 83.03M | 129.19M | 129.19M |
| Repurchase of Common Stock | -207.00K | -207.00K | -207.00K | -207.00K | -1.40M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -803.00K | -772.00K | -847.00K | -2.58M | -1.16M |
| Cash from Financing | -9.65M | 73.13M | 89.11M | 127.77M | 133.67M |
| Foreign Exchange rate Adjustments | -3.41M | -1.07M | -2.75M | 1.01M | 1.93M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 1.00K | 1.00K | -1.00K | -1.00K |
| Net Change in Cash | -89.23M | 4.67M | 6.54M | 91.73M | 64.66M |